Generate a tailored SOP for Dr. Daniel Parker. Improve your application with a focused, well-structured draft.
Daniel Christopher Parker is an Associate Professor in the Department of Neurology at Duke University, where he leads research focused on Alzheimer's disease and related dementias (ADRD). As a regional leader in the application of amyloid-targeted therapies, including lecanemab and donanemab, he is at the forefront of clinical research aiming to develop disease-modifying treatments for early Alzheimer's disease. Dr. Parker also serves as the director of the Duke Memory Disorders Clinic, enhancing the clinical management of patients suffering from dementia. His research interests are centered on the development and utilization of innovative treatments to address the challenges posed by neurodegenerative diseases, and he has published extensively on the implications of genetic and epigenetic factors in aging and cognitive decline.
Duke University • Durham, NC
Associate Professor in the Department of Neurology and Medicine, specializing in clinical research on Alzheimer's disease.
Duke University • Durham, NC
Previously held the position of Assistant Professor in the Department of Neurology and Medicine.
Department of Biomedical Engineering (MS program)